Results 221 to 230 of about 2,510,208 (357)
Acute-Withdrawal Restless Legs Syndrome Following Abrupt Cessation of Short-Term Tramadol [PDF]
Young Min Park+4 more
openalex +1 more source
Pediatric Topical Steroid Withdrawal Syndrome: What Is Known, What Is Unknown. [PDF]
Ahuja K, Lio P.
europepmc +1 more source
Abstract Objective Assess the prevalence, characteristics, and healthcare resource utilization (HCRU) of patients prescribed certain benzodiazepines for seizure‐emergency management in the United Kingdom. Methods Retrospective cohort study using Clinical Practice Research Datalink (CPRD‐Aurum) and Hospital Episode Statistics (HES) data that included ...
Yuanjun Ma+5 more
wiley +1 more source
Neonatal withdrawal syndrome: Case report
Tatjana Radunovic-Gojkovic+1 more
openalex +2 more sources
A Case of Tizanidine Withdrawal Syndrome: Features and Management in the Emergency Department. [PDF]
Morgom M+6 more
europepmc +1 more source
Clinical applications of urinary sodium in heart failure from prognostic marker to clinical tool
ESC Heart Failure, EarlyView.
Dauw Jeroen
wiley +1 more source
Abstract Objective To investigate the efficacy and tolerability of perampanel (PER) on Dravet syndrome in China by a prospective real‐world study. Methods We prospectively enrolled children with Dravet syndrome from the neurology clinic of Shenzhen Children's Hospital from September 2020 to October 2021.
Han Wang+9 more
wiley +1 more source
The Effect of a Caffeine and Nicotine Combination on Nicotine Withdrawal Syndrome in Mice. [PDF]
Chen Z+11 more
europepmc +1 more source
Rest‐activity rhythm phenotypes in adults with epilepsy and intellectual disability
Abstract Objective Rest‐activity rhythms (RARs) are perturbed in many forms of neuropsychiatric illness. In this study, we applied wrist actigraphy to describe RAR perturbations in intellectually disabled adults with epilepsy (“E + ID”), using a cross‐sectional case–control design.
Nandani Adhyapak+3 more
wiley +1 more source
Precision therapies for genetic epilepsies in 2025: Promises and pitfalls
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang+3 more
wiley +1 more source